CMS issues final rule for 2027 Medicare Physician Fee Schedule
The US agency has finalised Medicare payment policy changes and other Part B issues taking effect on or after 1 January 2027, though provision-level detail is not yet available.
The US Centers for Medicare & Medicaid Services (CMS) has published the final rule for the calendar year (CY) 2027 Medicare Physician Fee Schedule. The item is dated 4 November 2026.
According to the summary on file, the rule finalises changes to Medicare payment policy and addresses other Part B issues. The changes apply to services furnished on or after 1 January 2027.
The excerpt available to VigiEye does not set out any specific provisions. It is therefore not possible to say how the rule affects Part B drug payment, reimbursement levels or market access.
As general context, the Physician Fee Schedule is the annual instrument through which CMS sets Medicare payment rates and related policies for services provided by physicians and certain other practitioners under Part B. Its provisions can be relevant to manufacturers and providers beyond clinician payment, so the full text will need review.
What it means for your team
- Market-access and reimbursement teams should read the full final rule before drawing conclusions on Part B drug payment, as the available summary gives no provision-level detail.
- Regulatory affairs staff should note the 1 January 2027 effective date when planning for any Part B-related changes.
- No impact on specific products or payment rates can be assessed until the rule's contents are confirmed.
Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.
Market accessCompany releaseMedicare begins paying for Lucid's EsoGuard as PAVmed's Veris nears FDA 510(k) filing
Market accessOfficialDenmark updates Voltabak eye drop supply notice, with shortage expected to run to mid-May 2027
Market accessOfficialMethergin 0.2 mg/ml injection withdrawn from Danish market, DKMA reports
Market accessOfficialDenmark updates import window for estradiol 25 microgram patches in supply failure
Market accessOfficialDKMA updates Vivelle Dot 37.5 supply notice: shortage expected to last until end of December
Market accessOfficial